Differential effects of immunotherapy with antibodies targeting α-synuclein oligomers and fibrils in a transgenic model of synucleinopathy.
about
A novel panel of α-synuclein antibodies reveal distinctive staining profiles in synucleinopathies.Multiple system atrophy: experimental models and reality.Tau oligomers mediate α-synuclein toxicity and can be targeted by immunotherapy.Region-Specific Effects of Immunotherapy With Antibodies Targeting α-synuclein in a Transgenic Model of Synucleinopathy.Proteasome-targeted nanobodies alleviate pathology and functional decline in an α-synuclein-based Parkinson's disease modelImmunotherapy targeting toll-like receptor 2 alleviates neurodegeneration in models of synucleinopathy by modulating α-synuclein transmission and neuroinflammation
P2860
Differential effects of immunotherapy with antibodies targeting α-synuclein oligomers and fibrils in a transgenic model of synucleinopathy.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Differential effects of immuno ...... enic model of synucleinopathy.
@en
Differential effects of immuno ...... enic model of synucleinopathy.
@nl
type
label
Differential effects of immuno ...... enic model of synucleinopathy.
@en
Differential effects of immuno ...... enic model of synucleinopathy.
@nl
prefLabel
Differential effects of immuno ...... enic model of synucleinopathy.
@en
Differential effects of immuno ...... enic model of synucleinopathy.
@nl
P2093
P2860
P1476
Differential effects of immuno ...... enic model of synucleinopathy.
@en
P2093
Anthony Adame
Cassia Overk
Changyoun Kim
Jazmin Florio
Michael Mante
Nishant Vaikath
Nour Majbour
Omar El-Agnaf
Robert A Rissman
Seung-Jae Lee
P2860
P356
10.1016/J.NBD.2017.05.002
P577
2017-05-02T00:00:00Z